Skip to application
All calculators and tools

Preparation. Administration. Evidence.

IV Dilution &
Medication Reference

Search 255 medications, read preserved historical references, and inspect separately reviewed preparation statements. Full monograph updates remain pending.

Version 6.4Release date 2026-11-04For healthcare professionals
Back to resultsA-Z list

Medication reference

Rifampin

Monograph awaiting updateThis monograph will be updated in the future.

Jump to a section

Historical source. Current clinical review is incomplete. This monograph will be updated in the future.

Rifampin (opens in a new tab)Original source URL: https://globalrph.com/dilution/rifampin/ | Retrieved 2026-11-04

Source dates, location and integrity

This historical article is separate from the reviewed claim cards. Product formulations and source dates may differ.

Original source URL
https://globalrph.com/dilution/rifampin/ (opens in a new tab)
Source date
Not established in the retrieved source
Retrieved
2026-11-04T19:50:40.597907+00:00
Source location
div.post-content
Packaged content SHA-256
1d8487ae6674731c310050e2063cc2a4307b83abb51efc3ece8f7f9a674ff7b1
Original response SHA-256
17c5ba835d7eabec025c78f79debaac8db9dc2ac0752e4f54cb453081a4f9038
Source body SHA-256
086d78732ac0179e9fb12ca6b6f2e2b35ba4a81f6e9652304420ae5e9d6c4ce8

Rifampin

The authors make no claims of the accuracy of the information contained herein; and these suggested doses and/or guidelines are not a substitute for clinical judgment. Neither GlobalRPh Inc. nor any other party involved in the preparation of this document shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user's use of or reliance upon this material. PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER.

Usual Diluents

D5W, NS

Standard Dilutions [Amount of drug] [Infusion volume] [Infusion rate]

Preparation of Solution for IV Infusion:
Reconstitute the lyophilized powder by transferring 10 mL of sterile water for injection to a vial containing 600 mg of rifampin for injection. Swirl vial gently to completely dissolve the antibiotic.
[Vial stability] The reconstituted solution contains 60 mg rifampin per mL and is stable at room temperature for up to 30 hours. Prior to administration, withdraw from the reconstituted solution a volume equivalent to the amount of rifampin calculated to be administered and add to 500 mL of infusion medium. Mix well and infuse at a rate allowing for complete infusion within 3 hours. Alternatively, the amount of rifampin calculated to be administered may be added to 100 mL of infusion medium and infused in 30 minutes.

[Admixture stability] Dilutions in dextrose 5% for injection (D5W) are stable at room temperature for up to 8 hours and should be prepared and used within this time. Precipitation of rifampin from the infusion solution may occur beyond this time. Dilutions in normal saline are stable at room temperature for up to 6 hours and should be prepared and used within this time. Other infusion solutions are not recommended. [July 2018]

Standard Dilutions [Amount of drug] [Infusion volume] [Infusion rate]
[600 mg] [500 ml] [3 hours]

Minimum dilution:
[300 - 600mg] [100 ml] [30 minutes]

Stability / Miscellaneous

DOSAGE AND ADMINISTRATION
=======================================
Rifampin can be administered by the oral route or by IV infusion. IV doses are the same as those for oral.

Tuberculosis
Adults: 10 mg/kg, in a single daily administration, not to exceed 600 mg/day, oral or IV.
Pediatric Patients: 10-20 mg/kg, not to exceed 600 mg/day, oral or IV.

Meningococcal Carriers
Adults: For adults, it is recommended that 600 mg rifampin be administered twice daily for two days.
Pediatric Patients: Pediatric patients 1 month of age or older: 10 mg/kg (not to exceed 600 mg per dose) every 12 hours for two days.
Pediatric patients under 1 month of age: 5 mg/kg every 12 hours for two days.

STABILITY:
=======================================
Dilutions in dextrose 5% for injection (D5W) are stable at room temperature for up to 8 hours and should be prepared and used within this time. Precipitation of rifampin from the infusion solution may occur beyond this time. Dilutions in normal saline are stable at room temperature for up to 6 hours and should be prepared and used within this time. Other infusion solutions are not recommended. [July 2018]

PREPARATION of Solution for IV Infusion :
=======================================
Reconstitute the lyophilized powder by transferring 10 mL of sterile water for injection to a vial containing 600 mg of rifampin for injection. Swirl vial gently to completely dissolve the antibiotic. The reconstituted solution contains 60 mg rifampin per mL and is stable at room temperature for up to 30 hours. Prior to administration, withdraw from the reconstituted solution a volume equivalent to the amount of rifampin calculated to be administered and add to 500 mL of infusion medium. Mix well and infuse at a rate allowing for complete infusion within 3 hours. Alternatively, the amount of rifampin calculated to be administered may be added to 100 mL of infusion medium and infused in 30 minutes.

Source: [package insert]

Open this historical article on its own

Product identifiers and clinical review status

This monograph will be updated in the future. Historical material is available where present in the original sources; full current exact-product and claim-level review remains pending.

Exact formulation, concentration, container, manufacturer, regulatory identifiers, and a reproducible label snapshot have not all been reconciled.

What remains to be completed
  • A retrieved source document is available; clinical reconciliation and a second-source claim map remain incomplete
  • Clinically reviewed, individually identified statements with two exact source mappings
  • Exact formulation, strength, container, manufacturer/labeler, application and NDC reconciliation
  • Renal-function methods and dialysis/CRRT modality review where applicable
  • Mechanism provenance, clinical source disagreements and full medication-specific safety reconciliation

Supplemental historical fields

Restored-data provenance and review notes

Source release: 2026-08-31. Current clinical review is incomplete. Original uses of current, verified, or normalized describe the historical source. They do not inherit the status of separately reviewed statements. Product formulations and source dates can differ.

Current review annotations for historical renal, dialysis, mechanism, and product fieldsSeparate renal reference: Open Renal Dosing Master (opens in a new tab)
Renal
Status
not_locally_normalized
Original classification
current_label_review_required
Entries
    General note
    Preserve the source-specific renal-function basis. An indexed CrCl table is not interchangeable with unindexed CrCl or eGFR. Generic advice to check a method does not identify the equation for a dose row.
    Dialysis
    Status
    no_local_structured_regimen
    Entries
      General note
      Named modality alone does not establish applicability. CRRT subtype, effluent rate, residual renal function, timing and interruptions require review. Historical absence is not evidence that no guidance exists.
      Mechanisms
      • Source kind
        first_look
        Local pointer
        /mechanism
        Original level
        drug_specific
        Provenance classification
        historical_drug_specific_uncorroborated
        Label derived verified
        false
        Independently corroborated
        false
        Exact label section
        Not recorded
        Original source note
        Not recorded
        Review status
        historical_unverified
        Note
        Drug-specific wording in the old file is not proof of independent corroboration or an exact label locator. Consult separately published current mechanism claims where present.
      • Source kind
        label_snapshot
        Local pointer
        /mechanism_summary
        Original level
        drug_specific
        Provenance classification
        historical_drug_specific_uncorroborated
        Label derived verified
        false
        Independently corroborated
        false
        Exact label section
        Not recorded
        Original source note
        GlobalRPh drug-specific mechanism summary retained alongside the selected DailyMed label.
        Review status
        historical_unverified
        Note
        Drug-specific wording in the old file is not proof of independent corroboration or an exact label locator. Consult separately published current mechanism claims where present.
      Future update
      Status
      pending_review
      Message
      This monograph will be updated in the future as current exact-product and claim-level review is completed.
      Source unavailable
      false
      Reason
      The historical content is restored; comprehensive contemporary verification remains incomplete.
      Historical first look: uses, mechanism, dosing context, and administration

      Recovered v5.1 source content; historical, awaiting current review.

      Id
      rifampin
      Source IDH51-F469B93B9E0C4DBA8545D135
      Generic name
      Rifampin
      Source IDH51-E2CABEDABDBF92E910AF3EF9
      Class
      Antibacterial
      Source IDH51-3EB3C6247B1F5A2F11D3DE02
      Subclass
      Legacy GlobalRPh directory entry
      Source IDH51-E51ED40AC269B1E91AA4477F
      Primary uses
      1. Selected susceptible bacterial infections; indication, site, organism, local susceptibility, and current labeling determine use.
        Source IDH51-34821E4644A30C0895AABC2C
      Mechanism
      Binds bacterial DNA-dependent RNA polymerase and suppresses RNA transcription.
      Source IDH51-0116259AFACDDCEF0EC87B37
      Mechanism level
      drug_specific
      Source IDH51-9EDE98EBF4EF874F29BD9FF0
      Basic dosing orientation
      Adult IV dosing is indication specific and usually part of combination therapy. Pediatric dosing is weight and indication specific. Neonatal use requires age-specific infectious-disease guidance.
      Source IDH51-D127E13C7BC11D61CD98965B
      Administration orientation
      Complete a 100 mL preparation in 30 minutes or a 500 mL preparation within 3 hours. Use a dedicated or compatibility-verified line; rifampin can discolor solutions and body fluids.
      Source IDH51-84CD3F33D3F143D7D0120A11
      Renal and population orientation
      Separate renal reference: Open Renal Dosing Master (opens in a new tab)Renal dosing status has not been locally normalized; use the current package insert before ordering or administration.
      Source IDH51-58687F17516DDA7E89BC5479
      Key safety orientation
      1. Rifampin is a potent enzyme inducer with extensive interactions. Monitor hepatic function and verify combination therapy.
        Source IDH51-2E6673BF668CB0191821C377
      2. Legacy content must be reconciled against current labeling and institutional policy before clinical use.
        Source IDH51-0519C9C2AAF8EE1EDF15B9D3
      Coverage path
      reviewed_local_label_summary
      Source IDH51-2E6671F4E131DE6017A0520E
      Coverage path label
      Reviewed local package-insert summary
      Source IDH51-78877942C34701761E687B5A
      Legacy title
      Rifampin
      Source IDH51-3A2D6E700A8FC01B4E955F16
      Review note
      First-look orientation only. Verify indication, patient population, weight basis, organ function, exact IV product, dose, concentration, compatibility, rate, and current labeling before use.
      Source IDH51-375689024B2425BC77F47841
      Search text
      Rifampin Antibacterial Legacy GlobalRPh directory entry Selected susceptible bacterial infections; indication, site, organism, local susceptibility, and current labeling determine use. Binds bacterial DNA-dependent RNA polymerase and suppresses RNA transcription. Adult IV dosing is indication specific and usually part of combination therapy. Pediatric dosing is weight and indication specific. Neonatal use requires age-specific infectious-disease guidance. Complete a 100 mL preparation in 30 minutes or a 500 mL preparation within 3 hours. Use a dedicated or compatibility-verified line; rifampin can discolor solutions and body fluids. Renal dosing status has not been locally normalized; use the current package insert before ordering or administration. Rifampin is a potent enzyme inducer with extensive interactions. Monitor hepatic function and verify combination therapy. Legacy content must be reconciled against current labeling and institutional policy before clinical use. Reviewed local package-insert summary
      Source IDH51-E03314AE538DEFC404BEE9EC
      Official access mode
      direct_label
      Source IDH51-238F202C206F1B685A4B8B53
      Official access reason
      A source-specific DailyMed label route is available.
      Source IDH51-7CA1931AF50763149CA6BF51
      Label snapshot available
      true
      Source IDH51-C175874966E1C43831E1D4A9
      Label snapshot setid
      036ab68e-5085-4edc-bd83-784b43d64eab
      Source IDH51-6F0F2030D12155E42145475B

      No separate structured rows were bundled for preparation, IV push, continuous infusion, population dosing, dialysis, CRRT. Historical article content and source links may cover these topics.

      Historical local label preparation summary

      Recovered v5.1 source content; historical, awaiting current review.

      Id
      rifampin
      Source IDH51-1B5FC290DE3B48D179534113
      Match names
      1. Rifampin
        Source IDH51-2525418BA157977720199B7D
      2. Rifadin IV
        Source IDH51-A6696C24E0E6BE492B3202DF
      Label title
      Rifampin for injection
      Source IDH51-E6C34ECEE5DAEE10FFD93332
      Brand names
      1. Rifadin IV
        Source IDH51-7D6E36CB74E46C20E4F10612
      Formulation
      RIFADIN IV is supplied as a 600 mg lyophilized single-dose vial.
      Source IDH51-4DA8C7A6FB44BBF4B20A4B99
      Reconstitution
      Reconstitute a 600 mg vial with 10 mL Sterile Water for Injection to produce approximately 60 mg/mL.
      Source IDH51-B3872F84BD036666AB600FFE
      Stock concentration
      Approximately 60 mg/mL after reconstitution.
      Source IDH51-65A6F53CEE16502136BC3182
      Diluents
      Further dilute in 5% dextrose injection or 0.9% sodium chloride injection as allowed by the exact label.
      Source IDH51-7B2D040A1FB2AE2295CEF2ED
      Final concentration
      Withdraw the calculated dose from the 60 mg/mL reconstituted vial and add it to either 100 mL or 500 mL of infusion medium, as directed by the current label.
      Source IDH51-9686E85F5C01EBDF899F0C74
      Containers
      Use 100 mL for a 30-minute infusion or 500 mL for an infusion completed within 3 hours.
      Source IDH51-632B8CDDDE1B3A2ED495083E
      Infusion time
      Complete a 100 mL preparation in 30 minutes or a 500 mL preparation within 3 hours.
      Source IDH51-21D95DF2E638A12A913DD74D
      Fluid restriction
      Use the reduced-volume option only within the exact label concentration and administration limits.
      Source IDH51-36F4D1583832B65AC63BEB99
      Stability
      The reconstituted 60 mg/mL vial solution is stable at room temperature for up to 30 hours. D5W dilutions should be used within 8 hours; normal-saline dilutions within 6 hours.
      Source IDH51-6668259E53698B22A66962CC
      Line filter
      Use a dedicated or compatibility-verified line; rifampin can discolor solutions and body fluids.
      Source IDH51-F025D976AD88130CE8BBCD33
      Adult applicability
      Adult IV dosing is indication specific and usually part of combination therapy.
      Source IDH51-BDC9517113E78FBFF9E4F0C1
      Pediatric applicability
      Pediatric dosing is weight and indication specific.
      Source IDH51-93463EA17B93DC393FCFB5C2
      Neonatal applicability
      Neonatal use requires age-specific infectious-disease guidance.
      Source IDH51-A9F071B93B32D101E75CA6A7
      Renal dialysis
      Separate renal reference: Open Renal Dosing Master (opens in a new tab)Renal adjustment is not usually the primary determinant, but hepatic function and interacting medicines require review.
      Source IDH51-06F0B4569AA378E17E691305
      Key warnings
      Rifampin is a potent enzyme inducer with extensive interactions. Monitor hepatic function and verify combination therapy.
      Source IDH51-4A92915A2BEBEA18DF02B075
      Catalog id
      rifampin
      Source IDH51-429C40C7945FF246A9EF854E
      Catalog name
      Rifampin
      Source IDH51-68F2748B0E41A48752D93E7E
      Review date
      2026-08-30
      Source IDH51-DC63F968E8B294B61A89B7CD
      Source type
      Reviewed local summary derived from official DailyMed labeling; exact marketed product must be checked.
      Source IDH51-5A626E8EECF536371DC3CFC1
      Official link type
      DailyMed official label
      Source IDH51-E242B47E6038F81F56658CF8
      Search text
      Rifampin Rifadin IV Rifadin IV rifampin rifampin Rifampin Rifampin for injection RIFADIN IV is supplied as a 600 mg lyophilized single-dose vial. Reconstitute a 600 mg vial with 10 mL Sterile Water for Injection to produce approximately 60 mg/mL. Approximately 60 mg/mL after reconstitution. Further dilute in 5% dextrose injection or 0.9% sodium chloride injection as allowed by the exact label. Withdraw the calculated dose from the 60 mg/mL reconstituted vial and add it to either 100 mL or 500 mL of infusion medium, as directed by the current label. Use 100 mL for a 30-minute infusion or 500 mL for an infusion completed within 3 hours. Complete a 100 mL preparation in 30 minutes or a 500 mL preparation within 3 hours. Use the reduced-volume option only within the exact label concentration and administration limits. The reconstituted 60 mg/mL vial solution is stable at room temperature for up to 30 hours. D5W dilutions should be used within 8 hours; normal-saline dilutions within 6 hours. Use a dedicated or compatibility-verified line; rifampin can discolor solutions and body fluids. Adult IV dosing is indication specific and usually part of combination therapy. Pediatric dosing is weight and indication specific. Neonatal use requires age-specific infectious-disease guidance. Renal adjustment is not usually the primary determinant, but hepatic function and interacting medicines require review. Rifampin is a potent enzyme inducer with extensive interactions. Monitor hepatic function and verify combination therapy. Current DailyMed label page located during the 2026-08-30 review; confirm the exact NDC and marketed product at the point of use. Reviewed local summary derived from official DailyMed labeling; exact marketed product must be checked. DailyMed official label 2026-08-30
      Source IDH51-B3496447FCB48F263E422C6E
      Label status
      Current DailyMed label page located during the 2026-08-30 review; confirm the exact NDC and marketed product at the point of use.
      Source IDH51-8E77E52A83AD483F4BAE0D56
      Label status level
      current
      Source IDH51-C76F305AD8D3128944C7EBA6

      Historical DailyMed label snapshot

      Recovered v5.1 source content; historical, awaiting current review.

      Id
      rifampin
      Source IDH51-481FC6ECFE9E968543985952
      Catalog name
      Rifampin
      Source IDH51-6BF265B2384D879CA43ECDB0
      Selection status
      accepted_high_confidence
      Source IDH51-D19738C359DA089446B555F8
      Confidence
      very_high
      Source IDH51-693C9894F68ACAF66617CAA8
      Match path
      existing_reviewed_summary
      Source IDH51-586DF05B1E066F2FCA82760A
      Brand name
      Rifadin IV
      Source IDH51-836B583B8C1C8DACA23BEA06
      Label title
      Rifampin for injection
      Source IDH51-6FC15F204ACF8ED6CD902702
      Setid
      036ab68e-5085-4edc-bd83-784b43d64eab
      Source IDH51-6037DD9DB5D94732CA96072A
      Reviewed on
      2026-08-31
      Source IDH51-93F89891E33201B7BEA2BE59
      Route
      Intravenous; see the selected product label for exact route and administration method.
      Source IDH51-82BE58B1E360B021A01BB2EB
      Dosage form
      RIFADIN IV is supplied as a 600 mg lyophilized single-dose vial.
      Source IDH51-219B18F638ED55AF97F592DF
      Dosage administration summary
      Separate renal reference: Open Renal Dosing Master (opens in a new tab)
      1. Adult IV dosing is indication specific and usually part of combination therapy.
        Source IDH51-E7A888349A964E0D18A93304
      2. Pediatric dosing is weight and indication specific.
        Source IDH51-D8DE0B6A76ED7CD60129A8D5
      3. Neonatal use requires age-specific infectious-disease guidance.
        Source IDH51-E055A728E233466409723940
      4. Reconstitute a 600 mg vial with 10 mL Sterile Water for Injection to produce approximately 60 mg/mL.
        Source IDH51-A8C28BC81CDAE1AAACC37195
      5. Complete a 100 mL preparation in 30 minutes or a 500 mL preparation within 3 hours.
        Source IDH51-C05379FB802593AF06C59E68
      6. Renal adjustment is not usually the primary determinant, but hepatic function and interacting medicines require review.
        Source IDH51-FAB57FA50B0F82B82C5E0F0A
      Dosage forms strengths
      1. RIFADIN IV is supplied as a 600 mg lyophilized single-dose vial.
        Source IDH51-4EAEDBE4276CEEC1DFD4D4BB
      2. Approximately 60 mg/mL after reconstitution.
        Source IDH51-2C5251B2F14FA1330C9BBD5A
      Mechanism summary
      Binds bacterial DNA-dependent RNA polymerase and suppresses RNA transcription.
      Source IDH51-13429CFD17199BF5A678224A
      Mechanism source
      GlobalRPh drug-specific mechanism summary retained alongside the selected DailyMed label.
      Source IDH51-E95E5263FE2901D9CE6A50ED
      Scope note
      The locally reviewed preparation summary remains the primary product-specific preparation snapshot. This broader label snapshot is concise and does not reproduce the full prescribing information.
      Source IDH51-CAE99A4F7CAFAE01853F5A43
      Source sections
      1. Dosage and Administration
        Source IDH51-5BD0529611EA2A54A6B52EB6
      2. Dosage Forms and Strengths
        Source IDH51-8001728798EC03C6B36056AD
      3. Clinical Pharmacology or Microbiology as applicable
        Source IDH51-5FD984008E17D6EFD5366223
      Retrieval method
      Manual build-time review of the current DailyMed full prescribing information for the selected Set ID; no live server retrieval is required during page use.
      Source IDH51-8C901BFF191EF7374C9CAA8A
      Label status
      current
      Source IDH51-B8AFA4EA3FEE1EF894629A88
      Disclaimer
      Verify the exact formulation, strength, manufacturer, NDC, route, current label revision, patient-specific order, institutional policy, and monitoring before use.
      Source IDH51-80ADBF6BCDC04DB606406D1C

      Historical renal-function guidance

      Recovered v5.1 source content; historical, awaiting current review.

      Separate renal reference: Open Renal Dosing Master (opens in a new tab)
      Classification
      current_label_review_required
      Source IDH51-09D400D63F6F7925922F7DA3
      Summary
      Renal dosing status has not been locally normalized; use the current package insert before ordering or administration.
      Source IDH51-1DCCF934FA15750F9CBD8848
      Method note
      Use the renal function estimate and body-size convention specified by the selected label or institutional protocol. Do not interchange Cockcroft-Gault CrCl, indexed eGFR, and de-indexed eGFR without confirming the dosing source.
      Source IDH51-5ED048D0CB66F8BEE60613B7

      Historical Warnings and safeguards

      Recovered v5.1 source content; historical, awaiting current review.

      1. Legacy content must be reconciled against current labeling and institutional policy before clinical use.
        Source IDH51-F35E7E26E5C48796CA8DD37D

      Historical Stability notes

      Recovered v5.1 source content; historical, awaiting current review.

      1. Legacy product stability information is not automatically equivalent to a USP <797> BUD.
        Source IDH51-4E2A9A665C9CAEBA38E04380

      Historical supplemental professional sources

      Recovered v5.1 source content; historical, awaiting current review.

      LabelUrlKind
      Source IDH51-38262BCEB7DE449D6A66480D
      UCSF adult antimicrobial dosing, non-dialysis
      Source IDH51-84B7E1B42EEBF083CE007DFD
      https://idmp.ucsf.edu/adult-antimicrobial-dosing-non-dialysis (opens in a new tab)
      Source IDH51-7A87528CD233DD04CFEFF192
      Professional institutional guidance
      Source IDH51-0062B50762FAFB9BF2A7398E
      Source IDH51-04A6AF5C1612F7D4DE475F93
      UCSF antimicrobial dosing in intermittent and continuous hemodialysis
      Source IDH51-E674D6C54E93A1008768C82D
      https://idmp.ucsf.edu/antimicrobial-dosing-intermittent-continuous-hemodialysis (opens in a new tab)
      Source IDH51-868182C20E34B7ABF8D761C5
      Professional institutional guidance
      Source IDH51-03FA1DF30338BC6625F51E4F
      Source IDH51-CCFB5184DB043ED7AB3A48D9
      UCSF pediatric antimicrobial dosing
      Source IDH51-E6B1D07070992A993B16AA5D
      https://idmp.ucsf.edu/pediatric-antimicrobial-dosing-benioff-childrens-hospitals (opens in a new tab)
      Source IDH51-C76C289D21F88F0A0BC4DDBB
      Professional institutional guidance
      Source IDH51-C8ED5DBBE78950DC6C46E174
      Source IDH51-9BA13BED9A99BDBE520E6CE1
      UCSF neonatal antimicrobial dosing
      Source IDH51-9476D300450DB3B644BBF3F4
      https://idmp.ucsf.edu/neonatal-antimicrobial-dosing-benioff-childrens-hospitals (opens in a new tab)
      Source IDH51-3AE104229F75494E4D8687EF
      Professional institutional guidance
      Source IDH51-E3ACEE7951F805D9E0F76227
      Other recovered source fields and original editorial metadata

      Original status words such as current, verified, or normalized describe the historical source release. They do not change the clinical review status of this release.

      Catalog source fields

      Id
      rifampin
      Source IDH51-0DCA64CB0BF1607FCCE9D472
      Legacy title
      Rifampin
      Source IDH51-3402EA904A721C9DE1B195A9
      Generic name
      Rifampin
      Source IDH51-0C34966F78CA4502830C4E65
      Class
      Antibacterial
      Source IDH51-BA0EE8CED27105FB446CBDF0
      Subclass
      Legacy GlobalRPh directory entry
      Source IDH51-A1E8FBE39C4C1A2A63A68B35
      Summary
      Existing GlobalRPh IV dilution monograph retained for migration into the unified reference.
      Source IDH51-BA9C5E7F6624A061763CAB92
      Populations
      1. Population not yet normalized
        Source IDH51-F1F964E0B4B5F4EA100A42AF
      Evidence tier
      Reviewed local label summary - exact product confirmation required
      Source IDH51-9164545B86FD6F653BDE36F0
      High alert
      false
      Source IDH51-28CDAE1B6A1FC3F4230CAC4C
      Hazardous
      false
      Source IDH51-92FBB2CB9A6B3A128C992EBD
      Status
      Legacy migration
      Source IDH51-9E45334D126430929ABE5FBB
      Reviewed
      2026-08-30
      Source IDH51-5A6672E2A2166C0E34417DAD
      Version added
      Legacy
      Source IDH51-AC6F0346D46304FB0B262001
      Sources
      LabelUrlKind
      Source IDH51-06934D849AF439E4D5399CF3
      GlobalRPh legacy IV dilution monograph
      Source IDH51-936E76BCD755F61F7D6FAB04
      legacy:auto
      Source IDH51-CBEBEEB515D827D0A0C829C7
      Legacy
      Source IDH51-2AF97D540F73680026A3626E
      Clinical release verification
      Audit version
      3.4
      Source IDH51-B8FD8766A507BB86A4C15747
      Audited on
      2026-08-30
      Source IDH51-3474070E2E945C750EE7D3CD
      Level
      amber
      Source IDH51-99F3E7551ED5C4FB961518EB
      Release gate
      trusted_professional_source_present_exact_label_unconfirmed
      Source IDH51-38E479AA820D4E411A9615A2
      Exact current label candidate
      false
      Source IDH51-FE0029F167FECB9AE9BF6FA5
      Reference url count
      4
      Source IDH51-732A27DD2CEB8820A4EFEA80
      Broken reference count
      0
      Source IDH51-FFC4B4CA6BA98AC99F964347
      Point of use confirmation required
      true
      Source IDH51-66844A6315946576FCA7E7B2
      Note
      Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
      Source IDH51-6436D0E887D45330159EB80C
      Dailymed search url
      https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Rifampin (opens in a new tab)
      Source IDH51-FCFA00ADB76854BCE3F88A6B
      Version updated
      3.8
      Source IDH51-DCBDD4A297EA31AB379FE531

      Dosing source fields

      Id
      rifampin
      Source IDH51-9791F2E9BD1F0749971623B3
      Generic name
      Rifampin
      Source IDH51-2B01014BA615572617FA2527
      Coverage status
      direct_official_label_access_plus_legacy_reference
      Source IDH51-CD59DA329667A3E66F124E87
      Package insert
      Query name
      Rifampin
      Source IDH51-2DCAAB13C6E992196519C525
      Product and route must match
      true
      Source IDH51-7C0EBDF445FD5F47755B8BEB
      Live current label enabled
      false
      Source IDH51-7C41885472A63AFCD13748FA
      Source priority
      Reviewed local summary when available, then a verified DailyMed label or product search when available, followed by professional references and institutional policy.
      Source IDH51-9D08B453CBC284375B786827
      Direct official label access enabled
      true
      Source IDH51-321420625DBE4D42CADE8DC8
      Outbound server request required
      false
      Source IDH51-254A1061458FAB30E0ABF2BA
      Local summary status
      current_reviewed_summary
      Source IDH51-6D7396EE6CFF52F5B8F94693
      Clinical review
      Locally normalized
      false
      Source IDH51-DF93AF526C09246B54C95C14
      Reviewed
      2026-08-29
      Source IDH51-53035B5D572978DB72B181F2
      Status
      Direct official package-insert access enabled; indication-specific local normalization pending.
      Source IDH51-9F99056C641E905F7DA0839F
      Clinical release verification
      Audit version
      3.4
      Source IDH51-645FE3D0959F18C478E70F23
      Audited on
      2026-08-30
      Source IDH51-A4B933761B5CB12F40A0D019
      Level
      amber
      Source IDH51-5072FDBC083F91AF5B516CFB
      Release gate
      trusted_professional_source_present_exact_label_unconfirmed
      Source IDH51-862FBFAD8DF7EEC084DFE570
      Exact current label candidate
      false
      Source IDH51-55D66C733CCA6878F598378B
      Reference url count
      4
      Source IDH51-A5C59FC1D0AA5F5E9316FA6A
      Broken reference count
      0
      Source IDH51-BFB9B77420A6707AAF439A06
      Point of use confirmation required
      true
      Source IDH51-D250F9FDA4CD1380069E04FA
      Note
      Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
      Source IDH51-DED50084BD139D154D2B156E
      Dailymed search url
      https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Rifampin (opens in a new tab)
      Source IDH51-4A26CED636B259C641D58258
      Historical preparation assessment

      Recovered v5.1 source content; historical, awaiting current review.

      Id
      rifampin
      Source IDH51-02E4FB76A547572A16557864
      Name
      Rifampin
      Source IDH51-F2CF0B10CB2F7D025084B802
      Therapeutic class
      Antibacterial
      Source IDH51-451CEF3CA6B18D8A060C248E
      Review version
      3.8
      Source IDH51-5EAF8E57FB421EDAE427DB9D
      Review date
      2026-08-30
      Source IDH51-4A6AC86AE2DC92B6B8A91A7A
      Release status
      reviewed_local_label_summary_exact_product_confirmation_required
      Source IDH51-751B35C37A39BA08DF87FDAD
      Market status
      Status
      current_dailymed_label_page_located_exact_product_verification_required
      Source IDH51-CABDA9AF35E31412BEA5DE20
      Basis
      Current DailyMed label page located during the 2026-08-30 review; confirm the exact NDC and marketed product at the point of use.
      Source IDH51-56E104B46604D1C04315ABC8
      Ten point assessment
      Exact formulation
      RIFADIN IV is supplied as a 600 mg lyophilized single-dose vial.
      Source IDH51-3282E84E495246CCC967B498
      Reconstitution concentration
      Reconstitute a 600 mg vial with 10 mL Sterile Water for Injection to produce approximately 60 mg/mL. Approximately 60 mg/mL after reconstitution.
      Source IDH51-6CBF681EA0204CE724E2B797
      Maximum or recommended final concentration
      Withdraw the calculated dose from the 60 mg/mL reconstituted vial and add it to either 100 mL or 500 mL of infusion medium, as directed by the current label.
      Source IDH51-1306D6342FFCBEA8CB7B6B18
      Appropriate standardized containers
      Use 100 mL for a 30-minute infusion or 500 mL for an infusion completed within 3 hours.
      Source IDH51-B4174DCC184E8B41A8B5B1EE
      Adult dosing range
      Adult IV dosing is indication specific and usually part of combination therapy.
      Source IDH51-82F6E13E8A24DF2A192425A1
      Pediatric dosing range
      Pediatric dosing is weight and indication specific.
      Source IDH51-93C4B67753BA672C4EA89698
      Neonatal dosing range
      Neonatal use requires age-specific infectious-disease guidance.
      Source IDH51-AADE8795749C81B3C1E5E707
      Infusion time
      Complete a 100 mL preparation in 30 minutes or a 500 mL preparation within 3 hours.
      Source IDH51-3C091E1ADC4A8C7F8619D99F
      Fluid restriction alternatives
      Use the reduced-volume option only within the exact label concentration and administration limits.
      Source IDH51-FCF97FA0945CCE2C4C6451E1
      Current manufacturer labeling
      Setid
      036ab68e-5085-4edc-bd83-784b43d64eab
      Source IDH51-3149B23F1CBCF037099E543A
      Title
      Rifampin for injection
      Source IDH51-CBD52DFCB58C92206CF59DDC
      Routes
      1. INTRAVENOUS
        Source IDH51-C491904B75102E74EF9CA4F2
      Match confidence
      reviewed_local_label_summary
      Source IDH51-DFBB67B21BBF6AFA2300A9AA
      Field provenance
      Exact formulation
      Primary
      official_dailymed_local_label_summary
      Source IDH51-736327DEA5C3F79E379F4DDB
      Reconstitution concentration
      Primary
      official_dailymed_local_label_summary
      Source IDH51-A1CC00A12AC0B93527B7A83A
      Maximum or recommended final concentration
      Primary
      official_dailymed_local_label_summary
      Source IDH51-F3194E66E1E8AC2F0250016E
      Appropriate standardized containers
      Primary
      official_dailymed_local_label_summary
      Source IDH51-35F1D64E72D6408B0360F8F7
      Adult dosing range
      Primary
      official_dailymed_local_label_summary
      Source IDH51-120FE3E8049E8356380D9B90
      Pediatric dosing range
      Primary
      official_dailymed_local_label_summary
      Source IDH51-999FEC991323DEAC9B4EE3FF
      Neonatal dosing range
      Primary
      official_dailymed_local_label_summary
      Source IDH51-CBC11A68A10A59AA28F988B6
      Infusion time
      Primary
      official_dailymed_local_label_summary
      Source IDH51-0BC186B8C0745AC5095F4401
      Fluid restriction alternatives
      Primary
      official_dailymed_local_label_summary
      Source IDH51-53BDCAE722DAB5D035208069
      Current manufacturer labeling
      Primary
      official_dailymed_local_label_summary
      Source IDH51-53E742354DE4500719DA33F6
      Population applicability
      Adult
      Applicability
      supported_or_source_present
      Source IDH51-097B5E4572E0E2B02EDBB723
      Guide generation allowed
      false
      Source IDH51-635213027D55FB9DFD66357A
      Pediatric
      Applicability
      supported_or_source_present
      Source IDH51-51637D4EF70A59B94300237D
      Guide generation allowed
      false
      Source IDH51-1216F3674A391161018BCDC8
      Neonatal
      Applicability
      not_established_or_requires_separate_guidance
      Source IDH51-17990709FEDA8FBB92C0A05F
      Guide generation allowed
      false
      Source IDH51-8CAE0EF9EC317DD4490D0C4B
      Route presence
      Structured dilution
      false
      Source IDH51-1AE4929DF2399A1CD0AF58F5
      Iv push
      false
      Source IDH51-FEA83BE437B6D9EB6C92DD25
      Continuous infusion
      false
      Source IDH51-C75E54FA76455E5A043DAEF9
      Pediatric source
      true
      Source IDH51-2812A57AC20C22F24F430997
      Neonatal source
      true
      Source IDH51-DB04A13FF2EB7B2714E40171
      Legacy reference
      Status
      not_available
      Source IDH51-3ADE5C6B1EDB7D5A29EC709B
      Label resolution
      Status
      reviewed_current_official_label_page
      Source IDH51-B6123090FAC764CDCB1F46BB
      Existing setids
      1. 036ab68e-5085-4edc-bd83-784b43d64eab
        Source IDH51-019489DF59C75E7C1DBFA490
      Review date
      2026-08-30
      Source IDH51-8CE2D8F80033A56EC964A8A3
      Source files
      1. catalog.json
        Source IDH51-FF60F58F3B66ED34FF64E5C4
      2. dosing.json
        Source IDH51-282D286B79CF6CA59380594C
      3. legacy-map.json
        Source IDH51-02DC717C0160E27729412DE6
      4. review-queue.json
        Source IDH51-DDD30658A81881D59D44E39C
      Clinical release note
      Reviewed local summary is available. Confirm exact formulation, NDC, manufacturer, route, current marketed status, compatibility, and institutional policy before use.
      Source IDH51-47E10B3C105207F622EA4C84
      Has bundled label summary
      true
      Source IDH51-0F717ABBC61A78F05B3DEEBE
      Bundled label summary id
      rifampin
      Source IDH51-8610A490168A442629FD781B
      Bundled label review date
      2026-08-30
      Source IDH51-3DA83353304D00CBB787D1FB
      Local label search
      rifampin Rifampin Rifadin IV Rifampin for injection Rifadin IV Lyophilized rifampin vial, commonly 600 mg. Reconstitute a 600 mg vial with 10 mL Sterile Water for Injection to produce approximately 60 mg/mL. Approximately 60 mg/mL after reconstitution. Further dilute in 5% dextrose injection or 0.9% sodium chloride injection as allowed by the exact label. Use a label-supported final volume; common preparations place 600 mg in 100 to 500 mL depending on infusion duration and fluid status. Common options include 100 mL for a shorter controlled infusion or 500 mL for a longer infusion, subject to the exact label. Administer by controlled infusion; common labeled options complete a 100 mL preparation in about 30 minutes or a 500 mL preparation within approximately 3 hours. Use the reduced-volume option only within the exact label concentration and administration limits. D5W and normal-saline preparations have different labeled stability windows; prepare and administer within the exact product limit. Use a dedicated or compatibility-verified line; rifampin can discolor solutions and body fluids. Adult IV dosing is indication specific and usually part of combination therapy. Pediatric dosing is weight and indication specific. Neonatal use requires age-specific infectious-disease guidance. Renal adjustment is not usually the primary determinant, but hepatic function and interacting medicines require review. Rifampin is a potent enzyme inducer with extensive interactions. Monitor hepatic function and verify combination therapy. rifampin Rifampin 2026-08-30 Reviewed local summary derived from official DailyMed labeling; exact marketed product must be checked. DailyMed official label
      Source IDH51-39AA6633159B8C9C5A070E52
      Aliases
      1. Rifampin for injection
        Source IDH51-9847126642531989EC48BEF7
      2. Approximately 60 mg/mL after reconstitution.
        Source IDH51-2A5C0BBE35E6B8A21E3FFE4D
      3. Further dilute in 5% dextrose injection or 0.9% sodium chloride injection as allowed by the exact label.
        Source IDH51-4F4C6C34012631634E89AB70
      4. Use a label-supported final volume; common preparations place 600 mg in 100 to 500 mL depending on infusion duration and fluid status.
        Source IDH51-5EB5058C52C6E8EDCA47D750
      5. Administer by controlled infusion; common labeled options complete a 100 mL preparation in about 30 minutes or a 500 mL preparation within approximately 3 hours.
        Source IDH51-F5E878FE2B07BD6A2625D5E7
      Local label summary
      Available
      true
      Source IDH51-3826DA96DCB5BEDDE7A56956
      Status level
      current
      Source IDH51-9A4E5C076F3B3BB5714D2F10
      Title
      Rifampin for injection
      Source IDH51-D28E129187706D57F071AEBA
      Historical statement IDs and source locations

      These IDs identify recovered source units. They are not evidence-qualified clinical claims.

      Historical IDOriginal source locationStatus
      H51-0DCA64CB0BF1607FCCE9D472catalog.json
      /records/221/id
      Historical; current review incomplete
      H51-3402EA904A721C9DE1B195A9catalog.json
      /records/221/legacy_title
      Historical; current review incomplete
      H51-0C34966F78CA4502830C4E65catalog.json
      /records/221/generic_name
      Historical; current review incomplete
      H51-BA0EE8CED27105FB446CBDF0catalog.json
      /records/221/class
      Historical; current review incomplete
      H51-A1E8FBE39C4C1A2A63A68B35catalog.json
      /records/221/subclass
      Historical; current review incomplete
      H51-BA9C5E7F6624A061763CAB92catalog.json
      /records/221/summary
      Historical; current review incomplete
      H51-F35E7E26E5C48796CA8DD37Dcatalog.json
      /records/221/warnings/0
      Historical; current review incomplete
      H51-4E2A9A665C9CAEBA38E04380catalog.json
      /records/221/stability_notes/0
      Historical; current review incomplete
      H51-F1F964E0B4B5F4EA100A42AFcatalog.json
      /records/221/populations/0
      Historical; current review incomplete
      H51-9164545B86FD6F653BDE36F0catalog.json
      /records/221/evidence_tier
      Historical; current review incomplete
      H51-28CDAE1B6A1FC3F4230CAC4Ccatalog.json
      /records/221/high_alert
      Historical; current review incomplete
      H51-92FBB2CB9A6B3A128C992EBDcatalog.json
      /records/221/hazardous
      Historical; current review incomplete
      H51-9E45334D126430929ABE5FBBcatalog.json
      /records/221/status
      Historical; current review incomplete
      H51-5A6672E2A2166C0E34417DADcatalog.json
      /records/221/reviewed
      Historical; current review incomplete
      H51-AC6F0346D46304FB0B262001catalog.json
      /records/221/version_added
      Historical; current review incomplete
      H51-06934D849AF439E4D5399CF3catalog.json
      /records/221/sources/0
      Historical; current review incomplete
      H51-936E76BCD755F61F7D6FAB04catalog.json
      /records/221/sources/0/label
      Historical; current review incomplete
      H51-CBEBEEB515D827D0A0C829C7catalog.json
      /records/221/sources/0/url
      Historical; current review incomplete
      H51-2AF97D540F73680026A3626Ecatalog.json
      /records/221/sources/0/kind
      Historical; current review incomplete
      H51-B8FD8766A507BB86A4C15747catalog.json
      /records/221/clinical_release_verification/audit_version
      Historical; current review incomplete
      H51-3474070E2E945C750EE7D3CDcatalog.json
      /records/221/clinical_release_verification/audited_on
      Historical; current review incomplete
      H51-99F3E7551ED5C4FB961518EBcatalog.json
      /records/221/clinical_release_verification/level
      Historical; current review incomplete
      H51-38E479AA820D4E411A9615A2catalog.json
      /records/221/clinical_release_verification/release_gate
      Historical; current review incomplete
      H51-FE0029F167FECB9AE9BF6FA5catalog.json
      /records/221/clinical_release_verification/exact_current_label_candidate
      Historical; current review incomplete
      H51-09C0AFE143D0CE13FAF23CE6catalog.json
      /records/221/clinical_release_verification/selected_setid
      Historical; current review incomplete
      H51-E2180243359635038B146DD9catalog.json
      /records/221/clinical_release_verification/selected_label_title
      Historical; current review incomplete
      H51-05A7431A2EA2569B6FB821C8catalog.json
      /records/221/clinical_release_verification/numeric_support_ratio
      Historical; current review incomplete
      H51-732A27DD2CEB8820A4EFEA80catalog.json
      /records/221/clinical_release_verification/reference_url_count
      Historical; current review incomplete
      H51-FFC4B4CA6BA98AC99F964347catalog.json
      /records/221/clinical_release_verification/broken_reference_count
      Historical; current review incomplete
      H51-66844A6315946576FCA7E7B2catalog.json
      /records/221/clinical_release_verification/point_of_use_confirmation_required
      Historical; current review incomplete
      H51-6436D0E887D45330159EB80Ccatalog.json
      /records/221/clinical_release_verification/note
      Historical; current review incomplete
      H51-FCFA00ADB76854BCE3F88A6Bcatalog.json
      /records/221/clinical_release_verification/dailymed_search_url
      Historical; current review incomplete
      H51-DCBDD4A297EA31AB379FE531catalog.json
      /records/221/version_updated
      Historical; current review incomplete
      H51-481FC6ECFE9E968543985952dailymed-label-snapshots-v5.1.json
      /records/42/id
      Historical; current review incomplete
      H51-6BF265B2384D879CA43ECDB0dailymed-label-snapshots-v5.1.json
      /records/42/catalog_name
      Historical; current review incomplete
      H51-D19738C359DA089446B555F8dailymed-label-snapshots-v5.1.json
      /records/42/selection_status
      Historical; current review incomplete
      H51-693C9894F68ACAF66617CAA8dailymed-label-snapshots-v5.1.json
      /records/42/confidence
      Historical; current review incomplete
      H51-586DF05B1E066F2FCA82760Adailymed-label-snapshots-v5.1.json
      /records/42/match_path
      Historical; current review incomplete
      H51-836B583B8C1C8DACA23BEA06dailymed-label-snapshots-v5.1.json
      /records/42/brand_name
      Historical; current review incomplete
      H51-6FC15F204ACF8ED6CD902702dailymed-label-snapshots-v5.1.json
      /records/42/label_title
      Historical; current review incomplete
      H51-A2BAB29C1EC29BC4E5424BA0dailymed-label-snapshots-v5.1.json
      /records/42/labeler
      Historical; current review incomplete
      H51-6037DD9DB5D94732CA96072Adailymed-label-snapshots-v5.1.json
      /records/42/setid
      Historical; current review incomplete
      H51-27555A34E9CA293B402D1771dailymed-label-snapshots-v5.1.json
      /records/42/official_label_url
      Historical; current review incomplete
      H51-93F89891E33201B7BEA2BE59dailymed-label-snapshots-v5.1.json
      /records/42/reviewed_on
      Historical; current review incomplete
      H51-82BE58B1E360B021A01BB2EBdailymed-label-snapshots-v5.1.json
      /records/42/route
      Historical; current review incomplete
      H51-219B18F638ED55AF97F592DFdailymed-label-snapshots-v5.1.json
      /records/42/dosage_form
      Historical; current review incomplete
      H51-E7A888349A964E0D18A93304dailymed-label-snapshots-v5.1.json
      /records/42/dosage_administration_summary/0
      Historical; current review incomplete
      H51-D8DE0B6A76ED7CD60129A8D5dailymed-label-snapshots-v5.1.json
      /records/42/dosage_administration_summary/1
      Historical; current review incomplete
      H51-E055A728E233466409723940dailymed-label-snapshots-v5.1.json
      /records/42/dosage_administration_summary/2
      Historical; current review incomplete
      H51-A8C28BC81CDAE1AAACC37195dailymed-label-snapshots-v5.1.json
      /records/42/dosage_administration_summary/3
      Historical; current review incomplete
      H51-C05379FB802593AF06C59E68dailymed-label-snapshots-v5.1.json
      /records/42/dosage_administration_summary/4
      Historical; current review incomplete
      H51-FAB57FA50B0F82B82C5E0F0Adailymed-label-snapshots-v5.1.json
      /records/42/dosage_administration_summary/5
      Historical; current review incomplete
      H51-4EAEDBE4276CEEC1DFD4D4BBdailymed-label-snapshots-v5.1.json
      /records/42/dosage_forms_strengths/0
      Historical; current review incomplete
      H51-2C5251B2F14FA1330C9BBD5Adailymed-label-snapshots-v5.1.json
      /records/42/dosage_forms_strengths/1
      Historical; current review incomplete
      H51-13429CFD17199BF5A678224Adailymed-label-snapshots-v5.1.json
      /records/42/mechanism_summary
      Historical; current review incomplete
      H51-E95E5263FE2901D9CE6A50EDdailymed-label-snapshots-v5.1.json
      /records/42/mechanism_source
      Historical; current review incomplete
      H51-CAE99A4F7CAFAE01853F5A43dailymed-label-snapshots-v5.1.json
      /records/42/scope_note
      Historical; current review incomplete
      H51-5BD0529611EA2A54A6B52EB6dailymed-label-snapshots-v5.1.json
      /records/42/source_sections/0
      Historical; current review incomplete
      H51-8001728798EC03C6B36056ADdailymed-label-snapshots-v5.1.json
      /records/42/source_sections/1
      Historical; current review incomplete
      H51-5FD984008E17D6EFD5366223dailymed-label-snapshots-v5.1.json
      /records/42/source_sections/2
      Historical; current review incomplete
      H51-8C901BFF191EF7374C9CAA8Adailymed-label-snapshots-v5.1.json
      /records/42/retrieval_method
      Historical; current review incomplete
      H51-B8AFA4EA3FEE1EF894629A88dailymed-label-snapshots-v5.1.json
      /records/42/label_status
      Historical; current review incomplete
      H51-80ADBF6BCDC04DB606406D1Cdailymed-label-snapshots-v5.1.json
      /records/42/disclaimer
      Historical; current review incomplete
      H51-9791F2E9BD1F0749971623B3dosing.json
      /records/221/id
      Historical; current review incomplete
      H51-2B01014BA615572617FA2527dosing.json
      /records/221/generic_name
      Historical; current review incomplete
      H51-CD59DA329667A3E66F124E87dosing.json
      /records/221/coverage_status
      Historical; current review incomplete
      H51-2DCAAB13C6E992196519C525dosing.json
      /records/221/package_insert/query_name
      Historical; current review incomplete
      H51-F8B3E8E3CD4814CA7550F920dosing.json
      /records/221/package_insert/preferred_setid
      Historical; current review incomplete
      H51-7C0EBDF445FD5F47755B8BEBdosing.json
      /records/221/package_insert/product_and_route_must_match
      Historical; current review incomplete
      H51-7C41885472A63AFCD13748FAdosing.json
      /records/221/package_insert/live_current_label_enabled
      Historical; current review incomplete
      H51-9D08B453CBC284375B786827dosing.json
      /records/221/package_insert/source_priority
      Historical; current review incomplete
      H51-321420625DBE4D42CADE8DC8dosing.json
      /records/221/package_insert/direct_official_label_access_enabled
      Historical; current review incomplete
      H51-254A1061458FAB30E0ABF2BAdosing.json
      /records/221/package_insert/outbound_server_request_required
      Historical; current review incomplete
      H51-6D7396EE6CFF52F5B8F94693dosing.json
      /records/221/package_insert/local_summary_status
      Historical; current review incomplete
      H51-09D400D63F6F7925922F7DA3dosing.json
      /records/221/renal/classification
      Historical; current review incomplete
      H51-1DCCF934FA15750F9CBD8848dosing.json
      /records/221/renal/summary
      Historical; current review incomplete
      H51-5ED048D0CB66F8BEE60613B7dosing.json
      /records/221/renal/method_note
      Historical; current review incomplete
      H51-38262BCEB7DE449D6A66480Ddosing.json
      /records/221/professional_sources/0
      Historical; current review incomplete
      H51-84B7E1B42EEBF083CE007DFDdosing.json
      /records/221/professional_sources/0/label
      Historical; current review incomplete
      H51-7A87528CD233DD04CFEFF192dosing.json
      /records/221/professional_sources/0/url
      Historical; current review incomplete
      H51-0062B50762FAFB9BF2A7398Edosing.json
      /records/221/professional_sources/0/kind
      Historical; current review incomplete
      H51-04A6AF5C1612F7D4DE475F93dosing.json
      /records/221/professional_sources/1
      Historical; current review incomplete
      H51-E674D6C54E93A1008768C82Ddosing.json
      /records/221/professional_sources/1/label
      Historical; current review incomplete
      H51-868182C20E34B7ABF8D761C5dosing.json
      /records/221/professional_sources/1/url
      Historical; current review incomplete
      H51-03FA1DF30338BC6625F51E4Fdosing.json
      /records/221/professional_sources/1/kind
      Historical; current review incomplete
      H51-CCFB5184DB043ED7AB3A48D9dosing.json
      /records/221/professional_sources/2
      Historical; current review incomplete
      H51-E6B1D07070992A993B16AA5Ddosing.json
      /records/221/professional_sources/2/label
      Historical; current review incomplete
      H51-C76C289D21F88F0A0BC4DDBBdosing.json
      /records/221/professional_sources/2/url
      Historical; current review incomplete
      H51-C8ED5DBBE78950DC6C46E174dosing.json
      /records/221/professional_sources/2/kind
      Historical; current review incomplete
      H51-9BA13BED9A99BDBE520E6CE1dosing.json
      /records/221/professional_sources/3
      Historical; current review incomplete
      H51-9476D300450DB3B644BBF3F4dosing.json
      /records/221/professional_sources/3/label
      Historical; current review incomplete
      H51-3AE104229F75494E4D8687EFdosing.json
      /records/221/professional_sources/3/url
      Historical; current review incomplete
      H51-E3ACEE7951F805D9E0F76227dosing.json
      /records/221/professional_sources/3/kind
      Historical; current review incomplete
      H51-DF93AF526C09246B54C95C14dosing.json
      /records/221/clinical_review/locally_normalized
      Historical; current review incomplete
      H51-53035B5D572978DB72B181F2dosing.json
      /records/221/clinical_review/reviewed
      Historical; current review incomplete
      H51-9F99056C641E905F7DA0839Fdosing.json
      /records/221/clinical_review/status
      Historical; current review incomplete
      H51-645FE3D0959F18C478E70F23dosing.json
      /records/221/clinical_release_verification/audit_version
      Historical; current review incomplete
      H51-A4B933761B5CB12F40A0D019dosing.json
      /records/221/clinical_release_verification/audited_on
      Historical; current review incomplete
      H51-5072FDBC083F91AF5B516CFBdosing.json
      /records/221/clinical_release_verification/level
      Historical; current review incomplete
      H51-862FBFAD8DF7EEC084DFE570dosing.json
      /records/221/clinical_release_verification/release_gate
      Historical; current review incomplete
      H51-55D66C733CCA6878F598378Bdosing.json
      /records/221/clinical_release_verification/exact_current_label_candidate
      Historical; current review incomplete
      H51-C2985571115142FCEB9ED2F7dosing.json
      /records/221/clinical_release_verification/selected_setid
      Historical; current review incomplete
      H51-FFD18CC76E5CCB884301B5B6dosing.json
      /records/221/clinical_release_verification/selected_label_title
      Historical; current review incomplete
      H51-846064A93DBA8F8100299218dosing.json
      /records/221/clinical_release_verification/numeric_support_ratio
      Historical; current review incomplete
      H51-A5C59FC1D0AA5F5E9316FA6Adosing.json
      /records/221/clinical_release_verification/reference_url_count
      Historical; current review incomplete
      H51-BFB9B77420A6707AAF439A06dosing.json
      /records/221/clinical_release_verification/broken_reference_count
      Historical; current review incomplete
      H51-D250F9FDA4CD1380069E04FAdosing.json
      /records/221/clinical_release_verification/point_of_use_confirmation_required
      Historical; current review incomplete
      H51-DED50084BD139D154D2B156Edosing.json
      /records/221/clinical_release_verification/note
      Historical; current review incomplete
      H51-4A26CED636B259C641D58258dosing.json
      /records/221/clinical_release_verification/dailymed_search_url
      Historical; current review incomplete
      H51-F469B93B9E0C4DBA8545D135first-look-v5.1.json
      /records/221/id
      Historical; current review incomplete
      H51-E2CABEDABDBF92E910AF3EF9first-look-v5.1.json
      /records/221/generic_name
      Historical; current review incomplete
      H51-3EB3C6247B1F5A2F11D3DE02first-look-v5.1.json
      /records/221/class
      Historical; current review incomplete
      H51-E51ED40AC269B1E91AA4477Ffirst-look-v5.1.json
      /records/221/subclass
      Historical; current review incomplete
      H51-34821E4644A30C0895AABC2Cfirst-look-v5.1.json
      /records/221/primary_uses/0
      Historical; current review incomplete
      H51-0116259AFACDDCEF0EC87B37first-look-v5.1.json
      /records/221/mechanism
      Historical; current review incomplete
      H51-9EDE98EBF4EF874F29BD9FF0first-look-v5.1.json
      /records/221/mechanism_level
      Historical; current review incomplete
      H51-D127E13C7BC11D61CD98965Bfirst-look-v5.1.json
      /records/221/basic_dosing_orientation
      Historical; current review incomplete
      H51-84CD3F33D3F143D7D0120A11first-look-v5.1.json
      /records/221/administration_orientation
      Historical; current review incomplete
      H51-58687F17516DDA7E89BC5479first-look-v5.1.json
      /records/221/renal_and_population_orientation
      Historical; current review incomplete
      H51-2E6673BF668CB0191821C377first-look-v5.1.json
      /records/221/key_safety_orientation/0
      Historical; current review incomplete
      H51-0519C9C2AAF8EE1EDF15B9D3first-look-v5.1.json
      /records/221/key_safety_orientation/1
      Historical; current review incomplete
      H51-2E6671F4E131DE6017A0520Efirst-look-v5.1.json
      /records/221/coverage_path
      Historical; current review incomplete
      H51-78877942C34701761E687B5Afirst-look-v5.1.json
      /records/221/coverage_path_label
      Historical; current review incomplete
      H51-BEFC49E082B78C7138160551first-look-v5.1.json
      /records/221/official_label_url
      Historical; current review incomplete
      H51-3A2D6E700A8FC01B4E955F16first-look-v5.1.json
      /records/221/legacy_title
      Historical; current review incomplete
      H51-375689024B2425BC77F47841first-look-v5.1.json
      /records/221/review_note
      Historical; current review incomplete
      H51-E03314AE538DEFC404BEE9ECfirst-look-v5.1.json
      /records/221/search_text
      Historical; current review incomplete
      H51-29C2D8DE2513151D8036DA0Efirst-look-v5.1.json
      /records/221/official_search_url
      Historical; current review incomplete
      H51-238F202C206F1B685A4B8B53first-look-v5.1.json
      /records/221/official_access_mode
      Historical; current review incomplete
      H51-A2F3D18F8CC0B335F6907A8Afirst-look-v5.1.json
      /records/221/official_access_url
      Historical; current review incomplete
      H51-751FC70319304A353762DBE6first-look-v5.1.json
      /records/221/official_search_query
      Historical; current review incomplete
      H51-7CA1931AF50763149CA6BF51first-look-v5.1.json
      /records/221/official_access_reason
      Historical; current review incomplete
      H51-C175874966E1C43831E1D4A9first-look-v5.1.json
      /records/221/label_snapshot_available
      Historical; current review incomplete
      H51-6F0F2030D12155E42145475Bfirst-look-v5.1.json
      /records/221/label_snapshot_setid
      Historical; current review incomplete
      H51-1B5FC290DE3B48D179534113local-label-summaries-v3.8.json
      /summaries/16/id
      Historical; current review incomplete
      H51-2525418BA157977720199B7Dlocal-label-summaries-v3.8.json
      /summaries/16/match_names/0
      Historical; current review incomplete
      H51-A6696C24E0E6BE492B3202DFlocal-label-summaries-v3.8.json
      /summaries/16/match_names/1
      Historical; current review incomplete
      H51-E6C34ECEE5DAEE10FFD93332local-label-summaries-v3.8.json
      /summaries/16/label_title
      Historical; current review incomplete
      H51-7D6E36CB74E46C20E4F10612local-label-summaries-v3.8.json
      /summaries/16/brand_names/0
      Historical; current review incomplete
      H51-4DA8C7A6FB44BBF4B20A4B99local-label-summaries-v3.8.json
      /summaries/16/formulation
      Historical; current review incomplete
      H51-B3872F84BD036666AB600FFElocal-label-summaries-v3.8.json
      /summaries/16/reconstitution
      Historical; current review incomplete
      H51-65A6F53CEE16502136BC3182local-label-summaries-v3.8.json
      /summaries/16/stock_concentration
      Historical; current review incomplete
      H51-7B2D040A1FB2AE2295CEF2EDlocal-label-summaries-v3.8.json
      /summaries/16/diluents
      Historical; current review incomplete
      H51-9686E85F5C01EBDF899F0C74local-label-summaries-v3.8.json
      /summaries/16/final_concentration
      Historical; current review incomplete
      H51-632B8CDDDE1B3A2ED495083Elocal-label-summaries-v3.8.json
      /summaries/16/containers
      Historical; current review incomplete
      H51-21D95DF2E638A12A913DD74Dlocal-label-summaries-v3.8.json
      /summaries/16/infusion_time
      Historical; current review incomplete
      H51-36F4D1583832B65AC63BEB99local-label-summaries-v3.8.json
      /summaries/16/fluid_restriction
      Historical; current review incomplete
      H51-6668259E53698B22A66962CClocal-label-summaries-v3.8.json
      /summaries/16/stability
      Historical; current review incomplete
      H51-F025D976AD88130CE8BBCD33local-label-summaries-v3.8.json
      /summaries/16/line_filter
      Historical; current review incomplete
      H51-BDC9517113E78FBFF9E4F0C1local-label-summaries-v3.8.json
      /summaries/16/adult_applicability
      Historical; current review incomplete
      H51-93463EA17B93DC393FCFB5C2local-label-summaries-v3.8.json
      /summaries/16/pediatric_applicability
      Historical; current review incomplete
      H51-A9F071B93B32D101E75CA6A7local-label-summaries-v3.8.json
      /summaries/16/neonatal_applicability
      Historical; current review incomplete
      H51-06F0B4569AA378E17E691305local-label-summaries-v3.8.json
      /summaries/16/renal_dialysis
      Historical; current review incomplete
      H51-4A92915A2BEBEA18DF02B075local-label-summaries-v3.8.json
      /summaries/16/key_warnings
      Historical; current review incomplete
      H51-429C40C7945FF246A9EF854Elocal-label-summaries-v3.8.json
      /summaries/16/catalog_id
      Historical; current review incomplete
      H51-68F2748B0E41A48752D93E7Elocal-label-summaries-v3.8.json
      /summaries/16/catalog_name
      Historical; current review incomplete
      H51-DC63F968E8B294B61A89B7CDlocal-label-summaries-v3.8.json
      /summaries/16/review_date
      Historical; current review incomplete
      H51-5A626E8EECF536371DC3CFC1local-label-summaries-v3.8.json
      /summaries/16/source_type
      Historical; current review incomplete
      H51-E242B47E6038F81F56658CF8local-label-summaries-v3.8.json
      /summaries/16/official_link_type
      Historical; current review incomplete
      H51-1EB7D30FEC209D803945D878local-label-summaries-v3.8.json
      /summaries/16/official_label_url
      Historical; current review incomplete
      H51-AB9EA6F9950F7BAEF8FC640Alocal-label-summaries-v3.8.json
      /summaries/16/official_search_url
      Historical; current review incomplete
      H51-B3496447FCB48F263E422C6Elocal-label-summaries-v3.8.json
      /summaries/16/search_text
      Historical; current review incomplete
      H51-8E77E52A83AD483F4BAE0D56local-label-summaries-v3.8.json
      /summaries/16/label_status
      Historical; current review incomplete
      H51-C76F305AD8D3128944C7EBA6local-label-summaries-v3.8.json
      /summaries/16/label_status_level
      Historical; current review incomplete
      H51-02E4FB76A547572A16557864preparation-assessments-v3.8.json
      /221/id
      Historical; current review incomplete
      H51-F2CF0B10CB2F7D025084B802preparation-assessments-v3.8.json
      /221/name
      Historical; current review incomplete
      H51-2459307814389279510B8A97preparation-assessments-v3.8.json
      /221/brands
      Historical; current review incomplete
      H51-451CEF3CA6B18D8A060C248Epreparation-assessments-v3.8.json
      /221/therapeutic_class
      Historical; current review incomplete
      H51-5EAF8E57FB421EDAE427DB9Dpreparation-assessments-v3.8.json
      /221/review_version
      Historical; current review incomplete
      H51-4A6AC86AE2DC92B6B8A91A7Apreparation-assessments-v3.8.json
      /221/review_date
      Historical; current review incomplete
      H51-751B35C37A39BA08DF87FDADpreparation-assessments-v3.8.json
      /221/release_status
      Historical; current review incomplete
      H51-CABDA9AF35E31412BEA5DE20preparation-assessments-v3.8.json
      /221/market_status/status
      Historical; current review incomplete
      H51-56E104B46604D1C04315ABC8preparation-assessments-v3.8.json
      /221/market_status/basis
      Historical; current review incomplete
      H51-3282E84E495246CCC967B498preparation-assessments-v3.8.json
      /221/ten_point_assessment/exact_formulation
      Historical; current review incomplete
      H51-6CBF681EA0204CE724E2B797preparation-assessments-v3.8.json
      /221/ten_point_assessment/reconstitution_concentration
      Historical; current review incomplete
      H51-1306D6342FFCBEA8CB7B6B18preparation-assessments-v3.8.json
      /221/ten_point_assessment/maximum_or_recommended_final_concentration
      Historical; current review incomplete
      H51-B4174DCC184E8B41A8B5B1EEpreparation-assessments-v3.8.json
      /221/ten_point_assessment/appropriate_standardized_containers
      Historical; current review incomplete
      H51-82F6E13E8A24DF2A192425A1preparation-assessments-v3.8.json
      /221/ten_point_assessment/adult_dosing_range
      Historical; current review incomplete
      H51-93C4B67753BA672C4EA89698preparation-assessments-v3.8.json
      /221/ten_point_assessment/pediatric_dosing_range
      Historical; current review incomplete
      H51-AADE8795749C81B3C1E5E707preparation-assessments-v3.8.json
      /221/ten_point_assessment/neonatal_dosing_range
      Historical; current review incomplete
      H51-3C091E1ADC4A8C7F8619D99Fpreparation-assessments-v3.8.json
      /221/ten_point_assessment/infusion_time
      Historical; current review incomplete
      H51-FCF97FA0945CCE2C4C6451E1preparation-assessments-v3.8.json
      /221/ten_point_assessment/fluid_restriction_alternatives
      Historical; current review incomplete
      H51-3149B23F1CBCF037099E543Apreparation-assessments-v3.8.json
      /221/ten_point_assessment/current_manufacturer_labeling/setid
      Historical; current review incomplete
      H51-CBD52DFCB58C92206CF59DDCpreparation-assessments-v3.8.json
      /221/ten_point_assessment/current_manufacturer_labeling/title
      Historical; current review incomplete
      H51-2CDD19D8F65C2FBC1359BDB1preparation-assessments-v3.8.json
      /221/ten_point_assessment/current_manufacturer_labeling/published_date
      Historical; current review incomplete
      H51-C72252A5DF3BB52083726B80preparation-assessments-v3.8.json
      /221/ten_point_assessment/current_manufacturer_labeling/manufacturer
      Historical; current review incomplete
      H51-C491904B75102E74EF9CA4F2preparation-assessments-v3.8.json
      /221/ten_point_assessment/current_manufacturer_labeling/routes/0
      Historical; current review incomplete
      H51-DFBB67B21BBF6AFA2300A9AApreparation-assessments-v3.8.json
      /221/ten_point_assessment/current_manufacturer_labeling/match_confidence
      Historical; current review incomplete
      H51-C77DB6555F8B7F221BDF82A9preparation-assessments-v3.8.json
      /221/ten_point_assessment/current_manufacturer_labeling/url
      Historical; current review incomplete
      H51-736327DEA5C3F79E379F4DDBpreparation-assessments-v3.8.json
      /221/field_provenance/exact_formulation/primary
      Historical; current review incomplete
      H51-A1CC00A12AC0B93527B7A83Apreparation-assessments-v3.8.json
      /221/field_provenance/reconstitution_concentration/primary
      Historical; current review incomplete
      H51-F3194E66E1E8AC2F0250016Epreparation-assessments-v3.8.json
      /221/field_provenance/maximum_or_recommended_final_concentration/primary
      Historical; current review incomplete
      H51-35F1D64E72D6408B0360F8F7preparation-assessments-v3.8.json
      /221/field_provenance/appropriate_standardized_containers/primary
      Historical; current review incomplete
      H51-120FE3E8049E8356380D9B90preparation-assessments-v3.8.json
      /221/field_provenance/adult_dosing_range/primary
      Historical; current review incomplete
      H51-999FEC991323DEAC9B4EE3FFpreparation-assessments-v3.8.json
      /221/field_provenance/pediatric_dosing_range/primary
      Historical; current review incomplete
      H51-CBC11A68A10A59AA28F988B6preparation-assessments-v3.8.json
      /221/field_provenance/neonatal_dosing_range/primary
      Historical; current review incomplete
      H51-0BC186B8C0745AC5095F4401preparation-assessments-v3.8.json
      /221/field_provenance/infusion_time/primary
      Historical; current review incomplete
      H51-53BDCAE722DAB5D035208069preparation-assessments-v3.8.json
      /221/field_provenance/fluid_restriction_alternatives/primary
      Historical; current review incomplete
      H51-53E742354DE4500719DA33F6preparation-assessments-v3.8.json
      /221/field_provenance/current_manufacturer_labeling/primary
      Historical; current review incomplete
      H51-097B5E4572E0E2B02EDBB723preparation-assessments-v3.8.json
      /221/population_applicability/adult/applicability
      Historical; current review incomplete
      H51-635213027D55FB9DFD66357Apreparation-assessments-v3.8.json
      /221/population_applicability/adult/guide_generation_allowed
      Historical; current review incomplete
      H51-51637D4EF70A59B94300237Dpreparation-assessments-v3.8.json
      /221/population_applicability/pediatric/applicability
      Historical; current review incomplete
      H51-1216F3674A391161018BCDC8preparation-assessments-v3.8.json
      /221/population_applicability/pediatric/guide_generation_allowed
      Historical; current review incomplete
      H51-17990709FEDA8FBB92C0A05Fpreparation-assessments-v3.8.json
      /221/population_applicability/neonatal/applicability
      Historical; current review incomplete
      H51-8CAE0EF9EC317DD4490D0C4Bpreparation-assessments-v3.8.json
      /221/population_applicability/neonatal/guide_generation_allowed
      Historical; current review incomplete
      H51-1AE4929DF2399A1CD0AF58F5preparation-assessments-v3.8.json
      /221/route_presence/structured_dilution
      Historical; current review incomplete
      H51-FEA83BE437B6D9EB6C92DD25preparation-assessments-v3.8.json
      /221/route_presence/iv_push
      Historical; current review incomplete
      H51-C75E54FA76455E5A043DAEF9preparation-assessments-v3.8.json
      /221/route_presence/continuous_infusion
      Historical; current review incomplete
      H51-2812A57AC20C22F24F430997preparation-assessments-v3.8.json
      /221/route_presence/pediatric_source
      Historical; current review incomplete
      H51-DB04A13FF2EB7B2714E40171preparation-assessments-v3.8.json
      /221/route_presence/neonatal_source
      Historical; current review incomplete
      H51-3ADE5C6B1EDB7D5A29EC709Bpreparation-assessments-v3.8.json
      /221/legacy_reference/status
      Historical; current review incomplete
      H51-B6123090FAC764CDCB1F46BBpreparation-assessments-v3.8.json
      /221/label_resolution/status
      Historical; current review incomplete
      H51-019489DF59C75E7C1DBFA490preparation-assessments-v3.8.json
      /221/label_resolution/existing_setids/0
      Historical; current review incomplete
      H51-EF7CD852E013650E2E25DD4Epreparation-assessments-v3.8.json
      /221/label_resolution/official_url
      Historical; current review incomplete
      H51-8CE2D8F80033A56EC964A8A3preparation-assessments-v3.8.json
      /221/label_resolution/review_date
      Historical; current review incomplete
      H51-FF60F58F3B66ED34FF64E5C4preparation-assessments-v3.8.json
      /221/source_files/0
      Historical; current review incomplete
      H51-282D286B79CF6CA59380594Cpreparation-assessments-v3.8.json
      /221/source_files/1
      Historical; current review incomplete
      H51-02DC717C0160E27729412DE6preparation-assessments-v3.8.json
      /221/source_files/2
      Historical; current review incomplete
      H51-DDD30658A81881D59D44E39Cpreparation-assessments-v3.8.json
      /221/source_files/3
      Historical; current review incomplete
      H51-47E10B3C105207F622EA4C84preparation-assessments-v3.8.json
      /221/clinical_release_note
      Historical; current review incomplete
      H51-0F717ABBC61A78F05B3DEEBEpreparation-assessments-v3.8.json
      /221/has_bundled_label_summary
      Historical; current review incomplete
      H51-8610A490168A442629FD781Bpreparation-assessments-v3.8.json
      /221/bundled_label_summary_id
      Historical; current review incomplete
      H51-3DA83353304D00CBB787D1FBpreparation-assessments-v3.8.json
      /221/bundled_label_review_date
      Historical; current review incomplete
      H51-39AA6633159B8C9C5A070E52preparation-assessments-v3.8.json
      /221/local_label_search
      Historical; current review incomplete
      H51-9847126642531989EC48BEF7preparation-assessments-v3.8.json
      /221/aliases/0
      Historical; current review incomplete
      H51-2A5C0BBE35E6B8A21E3FFE4Dpreparation-assessments-v3.8.json
      /221/aliases/1
      Historical; current review incomplete
      H51-4F4C6C34012631634E89AB70preparation-assessments-v3.8.json
      /221/aliases/2
      Historical; current review incomplete
      H51-5EB5058C52C6E8EDCA47D750preparation-assessments-v3.8.json
      /221/aliases/3
      Historical; current review incomplete
      H51-F5E878FE2B07BD6A2625D5E7preparation-assessments-v3.8.json
      /221/aliases/4
      Historical; current review incomplete
      H51-3826DA96DCB5BEDDE7A56956preparation-assessments-v3.8.json
      /221/local_label_summary/available
      Historical; current review incomplete
      H51-9A4E5C076F3B3BB5714D2F10preparation-assessments-v3.8.json
      /221/local_label_summary/status_level
      Historical; current review incomplete
      H51-D28E129187706D57F071AEBApreparation-assessments-v3.8.json
      /221/local_label_summary/title
      Historical; current review incomplete
      H51-072724CC765D79CD53D1CB60preparation-assessments-v3.8.json
      /221/local_label_summary/official_url
      Historical; current review incomplete